![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ID BIOMEDICAL SAYS NO RIVAL OFFER TO GLAXO BID
ID BIOMEDICAL SAYS NO RIVAL OFFER TO GLAXO BID
September 16, 2005
ID Biomedical Corp. <IDB.TO> has not received another takeover offer to rival Britain's GlaxoSmithKline Plc <GSK.L> $1.4 billion bid, the Canadian vaccine maker's chief executive said on Thursday. When asked if another company has made an offer, or if ID Biomedical has heard from another company, Anthony Holler said, "No we haven't."
"People have been asking me that, but we filed the agreement with regulators on Friday, so I suspect there are a number of people poring over that agreement and doing their own valuations of ID Biomedical in terms of whether they would look at making a higher offer," he told Reuters.
Metro Toronto (http://www.metronews.ca/reuters_business.asp?id=95693)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct